Table 8.
Summary statistics from meta-analyses of prevalence studies on the medications used to treat heart failure in sub-Saharan Africa.
| Treatment | N studies | N participants | % (95% confidence interval) | I² (95% confidence interval) | H (95% confidence interval) | P heterogeneity | P Egger test |
|---|---|---|---|---|---|---|---|
| ACEI/ARB | 9 | 5692 | 75.5 (64.4–85.1) | 98.8 (98.4–99.0) | 8.9 (7.8–10.2) | <0.0001 | 0.879 |
| Aldosterone antagonists | 6 | 4925 | 51.5 (32.4–70.3) | 99.4 (99.3–99.6) | 13.4 (11.8–15.2) | <0.0001 | 0.807 |
| Digoxin | 7 | 5027 | 31.5 (19.4–45.0) | 98.9 (98.6–99.2) | 9.6 (8.3–11.2) | <0.0001 | 0.924 |
| Loop diuretics | 9 | 5692 | 81.6 (72.7–89.1) | 98.4 (97.8–98.8) | 7.8 (6.7–9.0) | <0.0001 | 0.806 |
| β-Blockers | 9 | 5692 | 31.4 (22.6–41.0) | 98.1 (97.4–98.6) | 7.3 (6.3–8.5) | <0.0001 | 0.549 |
ACEI=Angiotensin II enzyme inhibitor; ARB=Angiotensin receptor blocker; N=frequency; CI=confidence interval.